Hematology & Flow Cytometry Markets to Undergo Dramatic Changes, Projects VPG in In-demand Report Now Available at MarketPublishers.com04 Oct 2016 • by Natalie Aster
LONDON – Over the next 5 years, ongoing developments in monoclonal antibodies, IT and lasers, molecular diagnostics, in tandem with growing insights into immunologic forces that regulate systemic disorders, will have a deep influence on the worldwide hematology and flow cytometry markets. The emergence of new monoclonal antibody and molecular diagnostic tests is likely to assist the progress of currently available procedures and provide basis for specific, sensitive and uncomplicated assays. The launch of easy-to-operate, smaller laser systems is set to further expand flow cytometry applications to routine clinical labs. Further advancements in IT will likely cut the cost of the production of instruments, service warranty, and enable the development of autocalibration, self-troubleshooting and other progressive features. Currently tedious analyses of DNA content, chromosomal abnormalities, and lymphocyte subsets are expected to be more automated and routine.
In-demand report “Hematology and Flow Cytometry Instruments and Reagents: Supplier Sales and Shares, Competitive Strategies, Country Volume and Sales Segment Forecasts, New Technologies, Instrumentation Review, Emerging Opportunities” created by VPG is designed to pinpoint and assess business opportunities arising in the worldwide flow cytometry and hematology markets in the coming few years worldwide, particularly across such key countries as the USA, France, the UK, Italy, Spain, Germany, and Japan.
The study presents an all-round overview of the facilities conducting hematology and flow cytometry testing based on country, and sales and test volume forecasts country-wise. It offers an insightful analysis of the market segmentation covering market share estimates and sales for top product suppliers country-wise; test and sales projections for more than 40 procedures based on country, test and market segment. The study investigates technological and business trends in the countries in question. It provides an analysis of the present-day and emerging hematology and flow cytometry tests, market shares and sales of instrument and reagent suppliers, instrument placements, product sales forecasts by market segment, present-day and emerging hematology and flow cytometry tests. The report gives an all-round overview of the major technologies and their applications; and identifies new product development and marketing opportunities facing suppliers. It provides an analysis of the competitive scenario and profiles the leading suppliers and emerging entrants to the market. Strategic recommendations are also available in the report.
More in-demand market research studies by the publisher can be found at VPG page.